FDA Approves Pain Drug with Fine Particle Technology

Oct 22, 2013

Philadelphia Business Journal

The Food and Drug Administration granted marketing approval for Zorvolex, an anti-inflammatory drug. The nonsteroidal anti-inflammatory drug is used to treat adult pain. Zorvolex, Iroko officials said, is the first lower-dose NSAID developed with the SoluMatrix fine particle technology approved by the FDA. That technology was developed by iCeutica, a Philadelphia company that has a partnership and licensing deal with Iroko. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments